↓ Skip to main content

Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials

Overview of attention for article published in Cardiovascular Diabetology, September 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials
Published in
Cardiovascular Diabetology, September 2022
DOI 10.1186/s12933-022-01585-7
Pubmed ID
Authors

Ofri Mosenzon, Matthew S. Capehorn, Alessandra De Remigis, Søren Rasmussen, Petra Weimers, Julio Rosenstock

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 16%
Researcher 2 6%
Student > Postgraduate 2 6%
Student > Ph. D. Student 1 3%
Unspecified 1 3%
Other 0 0%
Unknown 20 65%
Readers by discipline Count As %
Medicine and Dentistry 6 19%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Unspecified 1 3%
Economics, Econometrics and Finance 1 3%
Nursing and Health Professions 1 3%
Other 0 0%
Unknown 21 68%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2022.
All research outputs
#18,088,660
of 23,243,271 outputs
Outputs from Cardiovascular Diabetology
#1,022
of 1,418 outputs
Outputs of similar age
#282,306
of 433,447 outputs
Outputs of similar age from Cardiovascular Diabetology
#43
of 53 outputs
Altmetric has tracked 23,243,271 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,418 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,447 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.